Combined effects of ionizing radiation and 4-hydroperoxyifosfamide in vitro

Radiotherapy and Oncology

Volumn 46, Issue 3, 1998, Pages 279-283

  Latz, Detlev ^a   Schulze, Tobias ^a   Manegold, Christian ^b   Schraube, Peter ^a   Flentje, Michael ^c   Weber, Klaus J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cell cycle; Ifosfamide; Ionizing radiation; Radiochemotherapy

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL CYCLE; CHINESE HAMSTER; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL SURVIVAL; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; CRICETINAE; CRICETULUS; FEMALE; HUMANS; IFOSFAMIDE; LUNG; MELANOMA; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION, IONIZING; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031972217     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00194-1     Document Type: Article

References (27)

1. Arnold, H., Bourseaux, F. and Brock, N. Neuartige Krebs-Chemotherapeutika aus der Gruppe der zyklischen N-Lost-Phosphamidester. Naturwiss 45: 64-66, 1958.
2. Arnold, H. Über die Chemie neuer zytostatisch wirksamer N-Chloräthylphosphorsäure-diamide (abstract A IV-1a/5). Fifth Int. Congress Chemother., Wien, 1967.
3. Brade, W.P., Herdrich, K. and Varini, M. Ifosfamide - pharmacology, safety and therapeutic potential. Cancer Treat. Rev. 12: 1-47, 1985.
4. Brade, W.P., Seeber, S. and Herdrich, K. Experimental and clinical comparative activity of ifosfamide and cyclophosphamide. Cancer Chemother. Pharmacol. 18 (Suppl. 2): 1-9, 1986.
5. Brade, W.P., Herdrich, K. and Klein, H.O. Ifosfamide - dosing and scheduling. Contr. Oncol. 26: 22-52, 1987.
6. Brock, N. Zur pharmokologischen Charakterisierung zyklischer N-Lost-Phosphamidester als Krebs-Chemotherapeutika. Arzeim. Forsch. (Drug Res.) 8: 1-9, 1958.
7. Brock, N. and Wilmanns, H. Wirkung eines zyklischen N-Lost-Phosphamidesters auf experimentell erzeugte Tumoren der ratte. Chemotherapeutische Wirksamkeit und pharmokologische Eigenschaften von B 518 ASTA. Dtsch. Med. Wschr. 83: 453-458, 1958.
8. Crook, T.M., Souhami, R.L. and McLean, A.E.M. Cytotoxity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res. 46: 5029-5034, 1986.
9. Dirven, H.A.A.M., van Ommen, B. and van Bladeren, P.J. Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferase. Chem. Res. Toxicol. 9: 351-360, 1996.
10. Drings, P. European experience with ifosfamide in non-small cell lung cancer. Semin. Oncol. 16 (Suppl. 3): 22-30, 1990.
11. Fertil, B., Dertinger, H., Courdi, A. and Malaise, E.P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res. 99: 73-84, 1984.
12. Fleer, R. and Brendel, M. Toxicity, interstrand cross-links and DNA fragmentation induced by activated cyclophosphamide in yeast: comparative studies on 4-hydroperoxycyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard. Chem.-Biol. Interact. 39: 1-15, 1982.
13. Frankenberg-Schwager, M. Induction, repair and biological relevance of radiation-induced DNA lesions in eucaryotic cells. Radiat. Environ. Biophys. 29: 272-292, 1990.
14. Huang, C.C., McKernan, K., Pantano, J.R. and Sirianni, S.R. An in vitro metabolic activation assay using liver microsomes in diffusion chambers: induction of sister chromatid exchanges and chromosome aberrations by cyclophosphamide or ifosfamide in cultured human and Chinese hamster cells. Carcinogenesis 1: 37-40, 1980.
15. Iliakis, G. Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation. Int. J. Radiat. Biol. 53: 541-584, 1988.
16. Iliakis, G. The role of DNA strand breaks in ionizing radiation-induced killing of eukaryotic cells. BioEssays 13: 641-648, 1991.
17. Jaeger, A.H., Bogdahn, U., Apfel, R., Pfeufer, B. and Dekant, A. In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas. J. Cancer Res. Clin. Oncol. 119: 721-726, 1993.
18. Minna, J.D., Pass, H., Glatstein, E. and Ihde, D.C. Cancer of the lung. In: Cancer: Principles and Practise of Oncology, 3rd edn., pp. 591-705. Editors: V.T. DeVita, S. Hellman and S.A. Rosenberg. J.B. Lippincott, Philadelphia, PA, 1989.
19. Phillips, R.A. and Tolmach, L.J. Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat. Res. 29: 413-432, 1966.
20. Povirk, L.F. and Shuker, D.E. DNA damage and mutagenesis induced by nitrogen mustards. Mutat. Res. 318: 205-226, 1994.
21. Schraube, P., Bischoff, H., Manegold, C. and Latz, D. Radiochemotherapie inoperabler nichtkleinzelliger Lungentumoren (NSCLC) mit Iphosphamid. Strahlenther. Onkol. 172 (Suppl. I): 99, 1996.
22. Steel, G.G. and Peckham, M.J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5: 85-91, 1979.
23. Studzian, K., Kinas, R., Ciesielska, E. and Szmigiero, L. Effects of alkylating metabolites of ifosfamide and its bromoanalogues on DNA of Hela cells. Biochem. Pharmacol. 43: 937-943, 1992.
24. Tannock, I.F. Treatment of cancer with radiation and drugs. J. Clin. Oncol. 14: 3156-3174, 1996.
25. Tonkin, K.S., Kelland, L.R. and Steel, G.G. Chemotherapy-radiation interactions in human cervix carcinoma xenografts. Br. J. Cancer 58: 738-741, 1988.
26. Ulmer, W. Biophysical aspects of integrated combination of cytostatic drugs with radiotherapy. Part 1: In vitro investigations on the kinetics of activated isophosphamide metabolites and the determination of selective properties of DNA-interstrand and DNA-protein crosslinking mechanisms using 31P-NMR spectroscopy. Strahlenther. Onkol. 167: 427-433, 1991.
27. Wolf, M., Maasberg, M., Pfab, R. and Havemann, K. Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human cancer cell lines. Cancer Res. Clin. Oncol. 117 (Suppl. IV): 187-192, 1991.